Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Medlive runs an online platform for doctors in China and uses it to sell targeted advertising and marketing to drug companies.
Medlive is essentially a professional social network and information hub for Chinese doctors. Think of it as a LinkedIn plus a medical library, but built specifically for physicians. Doctors come to the platform to read the latest clinical research, earn continuing education credits, look up drug information, and discuss cases with peers. The company says it serves millions of registered healthcare professionals.
That audience is the whole business. Pharmaceutical and medical device companies want to reach doctors with precise, relevant marketing, and Medlive sells them the ability to do that. Instead of blanketing hospitals with sales reps, a drugmaker can pay Medlive to put its message in front of, say, oncologists in a specific province who have shown interest in a particular treatment. Medlive also offers tools for patient management and other digital services, but targeted marketing is the core money-maker. The pitch to advertisers is simple: we have the doctors, we know what they read, and we can prove the ad worked. The company listed on the Hong Kong Stock Exchange in 2021 and was formerly known as Kingyee. It operates in a crowded and regulated space, competing for doctors' attention with other digital health platforms and with the old-fashioned sales rep. Its fortunes are tied to how much drugmakers spend on digital promotion in China, which can swing with industry crackdowns and pricing reforms. That dependence on pharmaceutical marketing budgets is both its strength, because those budgets are large, and its vulnerability, because they are not entirely in its control.
Medlive's value comes down to trust: if doctors keep showing up for credible medical information, advertisers keep paying to be there. If the content feels like an ad dump, the doctors leave and the whole model wobbles. So the company walks a careful line, keeping the physician experience genuinely useful while quietly monetizing the attention it earns.
Saved answer 路 last researched 16 Nov 2026